DMAE Bitartrate
Pharmacokinetics and Blood-Brain Barrier Transport
DMAE (Dimethylaminoethanol), particularly as DMAE bitartrate, is ingested and absorbed, though specific pharmacokinetic data such as bioavailability, Tmax, and half-life are not detailed in the provided sources. Its key structural feature is its similarity to choline, but with one less methyl group. This structural difference is believed to facilitate more efficient crossing of the blood-brain barrier (BBB) compared to choline itself. Once in the central nervous system, research indicates that while DMAE administration increases brain choline levels, it does not directly translate to a proportional increase in acetylcholine (ACh) levels, suggesting a more complex mechanism than simple precursor supply.
Inhibition of Peripheral Choline Metabolism
The leading hypothesis for DMAE's nootropic effect, as described in available literature, centers on its role as an inhibitor of choline metabolism in non-neural tissues. By competing with or otherwise hindering enzymes responsible for choline uptake and utilization in the periphery, DMAE effectively 'spares' choline, leading to elevated concentrations in the bloodstream. This increased circulating choline is then more available for transport across the BBB into cholinergic neurons, where it can serve as a substrate for ACh synthesis. This indirect mechanism contrasts with direct precursors like CDP-Choline or Alpha-GPC which provide choline directly within the brain.
Acetylcholine Synthesis Pathway
The synthesis of acetylcholine is a rate-limited process catalyzed by the enzyme choline acetyltransferase (ChAT). This reaction requires two primary substrates: choline and acetyl-coenzyme A (Acetyl-CoA). By potentially increasing the availability of the choline substrate within the brain, DMAE may support or enhance the rate of ACh synthesis, provided Acetyl-CoA is not a limiting factor. However, the link is indirect; studies have failed to consistently demonstrate a direct increase in ACh following DMAE administration, leading to the theory that its effects may be more nuanced.
Other Potential Mechanisms
Alternative theories for DMAE's action exist. One possibility is that DMAE acts as a modulator or direct agonist at certain cholinergic receptors, coaxing them into action. This, coupled with the increased availability of choline, could theoretically lead to a greater net cholinergic output. Additionally, DMAE has been investigated for its role as a neuroprotectant. It may act as an antioxidant by integrating into the cell membrane structure, protecting it from certain types of oxidative damage. It may also participate in metabolic processes through methyl donation, further contributing to cellular health and potentially mitigating age-related cognitive decline.
What is DMAE Bitartrate? +
How does DMAE work? +
What is the best dose for DMAE? +
When is the best time to take DMAE? +
What are the main benefits of taking DMAE? +
Are there any side effects of DMAE? +
Do I need to cycle DMAE? +
What is the best form of DMAE? +
Who should take DMAE? +
Who should not take DMAE? +
Can I stack DMAE with other supplements? +
Is DMAE safe for long-term use? +
Can I get DMAE from food? +
Is there a difference between branded and generic DMAE? +
Does DMAE require a loading phase? +
Does DMAE interact with medications? +
Is DMAE a stimulant? +
Will DMAE help with anxiety? +
Everything About DMAE Bitartrate Article
What It Does
DMAE (Dimethylaminoethanol) is a nootropic compound structurally similar to choline, an essential nutrient vital for brain health. Found naturally in the brain and in fatty fish like salmon and sardines, DMAE is thought to support cognitive functions such as focus, memory, and mental clarity. Unlike more direct choline sources like Alpha-GPC, DMAE works through a more indirect pathway. It is believed to cross the blood-brain barrier effectively and may work by increasing the body's available pool of choline, which is a crucial building block for the neurotransmitter acetylcholine. Acetylcholine is key for learning, memory, and attention. Some users also report benefits for mood, skin health when applied topically, and even an increase in lucid dreaming.
The Science
The precise mechanism of DMAE is still being explored, but it's fundamentally different from other popular cholinergics. The leading theory suggests that DMAE doesn't directly convert into acetylcholine. Instead, it is thought to inhibit the breakdown and use of choline in tissues outside the brain. This 'choline-sparing' effect elevates choline levels in the bloodstream, making more of it available for transport into the brain to support acetylcholine production.
Acetylcholine synthesis depends on two key components: choline and Acetyl-CoA. By potentially increasing the availability of choline, DMAE supports one half of this critical equation. Other theories propose that DMAE might directly stimulate cholinergic receptors or act as a neuroprotective antioxidant, helping to shield brain cells from oxidative stress.
What The Research Says
The scientific evidence for DMAE is considered limited and is largely based on older studies. While intriguing, the findings are not definitive.
Concentration: A double-blind, placebo-controlled study in Germany found that DMAE had a beneficial effect on brain activity (measured by EEG) in individuals who felt they lacked mental efficiency, particularly in the brain regions associated with memory and recognition. ADHD: A 1975 study involving 74 children concluded that 500mg of DMAE was about as effective as the prescription drug Ritalin for improving behavior, learning, and reaction time. Cognitive Decline: Research in the elderly has produced mixed results. One 24-week trial in adults with mild cognitive impairment showed a positive trend, but it failed to reach statistical significance. An earlier 1977 study on patients with dementia found DMAE helped reduce anxiety and irritability but did not improve memory or cognitive scores. Memory (Animal Studies): A 2009 study in mice showed that a form of DMAE improved spatial memory and reaction time. Another study found DMAE was as effective as nicotine for enhancing memory in animals, though combining the two diminished the effect.
Overall, while there is a basis for its use, more modern, large-scale human trials are needed to confirm these potential benefits.
Dosing Guide
Clinical research has used a wide variety of DMAE doses, and there is no single established 'effective' dose.
Starting Dose: Many supplement products contain doses between 250mg and 500mg. Clinical Range: Studies have used doses ranging from 500mg per day (for ADHD) up to 1800mg per day (in divided doses for dementia). Red Flag: Be cautious of products containing less than 250mg, as this may be too low to produce noticeable effects based on the available research and common product formulations.
Forms Compared
DMAE Bitartrate: This is the most common form found in dietary supplements. The bitartrate salt is added for stability. It is cost-effective and the form used in most nootropic stacks. DMAE Pyroglutamate: A form used in some animal research, but not typically found in commercial supplements. Centrophenoxine (Lucidril): This is a pharmaceutical drug, not a supplement, that contains DMAE as its active component. It is prescribed in some countries for cognitive health in the elderly.
For supplement users, DMAE Bitartrate is the standard and most accessible choice.
When & How To Take It
There is no specific guidance on timing from the provided research. As a nootropic intended for focus and mental clarity, many users prefer to take DMAE in the morning or early afternoon. It can be taken with or without food. Given the anecdotal reports of lucid dreaming, some users may experiment with evening doses, but starting with morning use is recommended to assess tolerance and effects on wakefulness.
Stacking
DMAE is frequently included in pre-formulated nootropic stacks. It is often paired with:
Other Nootropics: Such as L-Tyrosine for focus or racetams (where legal) to support overall cognitive enhancement. Acetyl-CoA Precursors: Ingredients like Acetyl-L-Carnitine (ALCAR) may be a logical pairing, as ALCAR can provide the 'acetyl' group needed for acetylcholine synthesis, while DMAE may help increase choline availability.
Who Should Take It
Individuals looking for a subtle, non-stimulatory boost in focus, mental clarity, and concentration may consider DMAE. It could also be of interest to those exploring ways to enhance dream vividness or support long-term brain health, although the evidence for the latter is still developing.
Who Should NOT Take It
Due to the limited modern research, individuals who are pregnant, nursing, or have pre-existing medical conditions should consult with a healthcare professional before using DMAE. The source material did not specify contraindications, but caution is always advised when starting a new supplement.
The Bottom Line
DMAE is a lesser-known cholinergic nootropic with a unique, indirect mechanism of action. While older research and animal studies suggest potential benefits for focus, mood, and possibly ADHD, the overall body of evidence is limited. It is considered a more subtle nootropic compared to direct precursors like Alpha-GPC or CDP-Choline. For those looking to experiment with a different type of cholinergic support, DMAE offers a cost-effective option, typically dosed between 250-750mg per serving.
* These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before beginning any supplement regimen.